Annovis Bio (ANVS)
(Delayed Data from NYSE)
$6.81 USD
+0.26 (3.97%)
Updated Jun 3, 2024 04:00 PM ET
After-Market: $6.82 +0.01 (0.15%) 7:58 PM ET
2-Buy of 5 2
F Value C Growth B Momentum D VGM
Price, Consensus and EPS Surprise
ANVS 6.81 +0.26(3.97%)
Will ANVS be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for ANVS based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ANVS
AbbVie (ABBV) Skyrizi Gets CHMP Nod for Ulcerative Colitis in EU
Ultragenyx (RARE) DTX401 Meets Goals in Metabolic Disorder Study
ANVS: What are Zacks experts saying now?
Zacks Private Portfolio Services
AstraZeneca (AZN) Falls on Failure to Meet NSCLC Study OS Goal
Prothena (PRTA), Bristol Myers Tie Up for Second Neuro Candidate
Candel (CADL) Stock Skyrockets 431% Year to Date: Here's Why
Other News for ANVS
12 Health Care Stocks Moving In Friday's Intraday Session
Annovis Bio rises 18.3%
Largest borrow rate increases among liquid names
Largest borrow rate increases among liquid names
Annovis Announces New Publication in a Peer-Reviewed Journal